Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07171242

Shanghai Prospective Registry Study of Ischemic Stroke

Status
Recruiting
Phase
Study type
Observational
Enrollment
15,000 (estimated)
Sponsor
Qiang Dong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to conduct a prospective cohort study on patients with imaging-confirmed ischemic stroke based on the 4S database. The primary objectives are to investigate the incidence, clinical characteristics, risk factors, and pathophysiological mechanisms of young-onset stroke, as well as to analyze the evolving trends in the etiology of young-onset stroke in the Shanghai region over recent years. This includes examining the roles of traditional risk factors (such as hypertension and diabetes) and emerging factors (such as air pollution and lifestyle changes), and exploring the associations between these factors and patient outcomes. Additionally, the study will analyze the association between reperfusion therapies such as intravenous thrombolysis, acute-phase management, and secondary prevention with clinical outcomes. Finally, it will delve into the screening, treatment, and challenges associated with genetic young stroke patients with Farby syndrome, providing comprehensive information for regional stroke prevention and control strategies targeting young stroke patients.

Detailed description

This study is designed as a prospective cohort investigation utilizing data from the 4S database, focusing specifically on patients with imaging-confirmed ischemic stroke who are classified as having young-onset stroke (typically defined as occurring in individuals under 55 years of age). The purpose is to provide a thorough understanding of stroke in younger populations within the Shanghai region through collecting relevant clinical information of patients.

Conditions

Timeline

Start date
2024-12-01
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2025-09-12
Last updated
2025-09-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07171242. Inclusion in this directory is not an endorsement.